C123H152F3N39O10S5 — CID 158690061
3-(2-amino-3H-benzimidazol-5-yl)-6-(cyclohexylmethyl)-2-(3H-1,2,4-triazol-5-yl)benzenesulfonamide;3-(2-amino-1H-benzimidazol-4-yl)-6-(piperidin-4-ylmethyl)-2-(3H-1,2,4-triazol-5-yl)benzenesulfonamide;4-[3-(aminomethyl)-4-methyl-2-(4H-triazol-5-yl)phenyl]cyclohexan-1-amine;3-(3-azaspiro[5.5]undecan-3-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;1-(azetidin-3-ylmethyl)-4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]piperidine;3-[4-(azetidin-3-yl)phenyl]-6-(piperidin-4-ylmethyl)-2-(2H-tetrazol-5-yl)benzenesulfonamide (PubChem CID 158690061) has the molecular formula C123H152F3N39O10S5 and a molecular weight of 2554.16 g/mol. Its IUPAC name is 3-(2-amino-3H-benzimidazol-5-yl)-6-(cyclohexylmethyl)-2-(3H-1,2,4-triazol-5-yl)benzenesulfonamide;3-(2-amino-1H-benzimidazol-4-yl)-6-(piperidin-4-ylmethyl)-2-(3H-1,2,4-triazol-5-yl)benzenesulfonamide;4-[3-(aminomethyl)-4-methyl-2-(4H-triazol-5-yl)phenyl]cyclohexan-1-amine;3-(3-azaspiro[5.5]undecan-3-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;1-(azetidin-3-ylmethyl)-4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]piperidine;3-[4-(azetidin-3-yl)phenyl]-6-(piperidin-4-ylmethyl)-2-(2H-tetrazol-5-yl)benzenesulfonamide.
| Compound Name | 3-(2-amino-3H-benzimidazol-5-yl)-6-(cyclohexylmethyl)-2-(3H-1,2,4-triazol-5-yl)benzenesulfonamide;3-(2-amino-1H-benzimidazol-4-yl)-6-(piperidin-4-ylmethyl)-2-(3H-1,2,4-triazol-5-yl)benzenesulfonamide;4-[3-(aminomethyl)-4-methyl-2-(4H-triazol-5-yl)phenyl]cyclohexan-1-amine;3-(3-azaspiro[5.5]undecan-3-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;1-(azetidin-3-ylmethyl)-4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]piperidine;3-[4-(azetidin-3-yl)phenyl]-6-(piperidin-4-ylmethyl)-2-(2H-tetrazol-5-yl)benzenesulfonamide |
|---|---|
| PubChem CID | 158690061 |
| Molecular Formula | C123H152F3N39O10S5 |
| Molecular Weight | 2554.16 g/mol |
| Exact Mass | 2552.11 |
| IUPAC Name | 3-(2-amino-3H-benzimidazol-5-yl)-6-(cyclohexylmethyl)-2-(3H-1,2,4-triazol-5-yl)benzenesulfonamide;3-(2-amino-1H-benzimidazol-4-yl)-6-(piperidin-4-ylmethyl)-2-(3H-1,2,4-triazol-5-yl)benzenesulfonamide;4-[3-(aminomethyl)-4-methyl-2-(4H-triazol-5-yl)phenyl]cyclohexan-1-amine;3-(3-azaspiro[5.5]undecan-3-yl)-6-methyl-2-(2H-tetrazol-5-yl)benzenesulfonamide;1-(azetidin-3-ylmethyl)-4-[4-[3-methylsulfonyl-2-(2H-tetrazol-5-yl)-4-(trifluoromethyl)phenyl]phenyl]piperidine;3-[4-(azetidin-3-yl)phenyl]-6-(piperidin-4-ylmethyl)-2-(2H-tetrazol-5-yl)benzenesulfonamide |
| SMILES | CS(=O)(=O)c1c(C(F)(F)F)ccc(-c2ccc(C3CCN(CC4CNC4)CC3)cc2)c1-c1nn[nH]n1.Cc1ccc(C2CCC(N)CC2)c(C2=NN=NC2)c1CN.Cc1ccc(N2CCC3(CCCCC3)CC2)c(-c2nn[nH]n2)c1S(N)(=O)=O.NS(=O)(=O)c1c(CC2CCNCC2)ccc(-c2ccc(C3CNC3)cc2)c1-c1nn[nH]n1.Nc1nc2c(-c3ccc(CC4CCNCC4)c(S(N)(=O)=O)c3C3=NCN=N3)cccc2[nH]1.Nc1nc2ccc(-c3ccc(CC4CCCCC4)c(S(N)(=O)=O)c3C3=NCN=N3)cc2[nH]1 |
| InChI | InChI=1S/C24H27F3N6O2S.C22H27N7O2S.C22H25N7O2S.C21H24N8O2S.C18H26N6O2S.C16H23N5/c1-36(34,35)22-20(24(25,26)27)7-6-19(21(22)23-29-31-32-30-23)18-4-2-16(3-5-18)17-8-10-33(11-9-17)14-15-12-28-13-15;23-32(30,31)21-17(11-14-7-9-24-10-8-14)5-6-19(20(21)22-26-28-29-27-22)16-3-1-15(2-4-16)18-12-25-13-18;23-22-27-17-9-7-14(11-18(17)28-22)16-8-6-15(10-13-4-2-1-3-5-13)20(32(24,30)31)19(16)21-25-12-26-29-21;22-21-27-16-3-1-2-15(18(16)28-21)14-5-4-13(10-12-6-8-24-9-7-12)19(32(23,30)31)17(14)20-25-11-26-29-20;1-13-5-6-14(15(16(13)27(19,25)26)17-20-22-23-21-17)24-11-9-18(10-12-24)7-3-2-4-8-18;1-10-2-7-13(11-3-5-12(18)6-4-11)16(14(10)8-17)15-9-19-21-20-15/h2-7,15,17,28H,8-14H2,1H3,(H,29,30,31,32);1-6,14,18,24-25H,7-13H2,(H2,23,30,31)(H,26,27,28,29);6-9,11,13H,1-5,10,12H2,(H3,23,27,28)(H2,24,30,31);1-5,12,24H,6-11H2,(H3,22,27,28)(H2,23,30,31);5-6H,2-4,7-12H2,1H3,(H2,19,25,26)(H,20,21,22,23);2,7,11-12H,3-6,8-9,17-18H2,1H3 |
| InChIKey | IGFPCVQXWXPXSC-UHFFFAOYSA-N |
| XLogP | 15.67 |
| TPSA | 765.44 Ų |
| H-Bond Donors | 17 |
| H-Bond Acceptors | 40 |
| Rotatable Bonds | 28 |
| Heavy Atoms | 180 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2554.16 |
| LogP ≤ 5 | 15.67 |
| H-Bond Donors ≤ 5 | 17 |
| H-Bond Acceptors ≤ 10 | 40 |